Study: Low-battery defib revisions costly

A Boston Scientific-sponsored study finds that replacing implantable cardiac devices due to battery expirations adds extra costs and complications.

Boston Scientific, Circulation: Cardiovascular Quality and Outcomes

News Well, Clinical Trials, Cardiac Rhythm Management

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1HVkoII